Boehringer Ingelheim Corporation and Eli Lilly and Company Release: Phase III Safety and Efficacy Data of Trajenta® (linagliptin) in Elderly People With Type 2 Diabetes Published in The Lancet Published: Aug 15, 2013 Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today! Related links BioSpace.com This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news